Evidence map›Paper›PMID 30307313›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2019

Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice.

Amrit Kumar Shrestha, Matthew L Bettini, Renuka T Menon, Vashisht Y N Gopal, Shixia Huang, Dean P Edwards, Mohan Pammi, Roberto Barrios, Binoy Shivanna

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. The Human Microbiome-A Physiologic Perspective.Comprehensive Physiology · 2024
    Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Amrit Kumar ShresthaSection of Neonatology, Department of Pediatrics, Baylor College of Medicine , Houston, Texas.
Matthew L BettiniSection of Diabetes and Endocrinology, Department of Pediatrics, McNair Medical Institute, Baylor College of Medicine , Houston, Texas.
Renuka T MenonSection of Neonatology, Department of Pediatrics, Baylor College of Medicine , Houston, Texas.
Vashisht Y N GopalDepartment of Melanoma Medical Oncology and Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Shixia HuangDepartment of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine , Houston, Texas.
Dean P EdwardsDepartment of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine , Houston, Texas.
Mohan PammiSection of Neonatology, Department of Pediatrics, Baylor College of Medicine , Houston, Texas.
Roberto BarriosDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital , Houston, Texas.
Binoy ShivannaSection of Neonatology, Department of Pediatrics, Baylor College of Medicine , Houston, Texas.
Baylor College of Medicine · USMethodist Hospital · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Self-Reactive T Cell Development in Type 1 DiabetesR01DK114456 · NIDDK · UNIVERSITY OF UTAH · PI BETTINI, MATTHEW · 2018 to 2022
$1.9M
Modulation of Neonatal Hyperoxic Lung Injury by the Aryl Hydrocarbon ReceptorK08HD073323 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI SHIVANNA, BINOY · 2013 to 2017
$649k
NCI NIH HHS P30 CA125123NICHD NIH HHS K08 HD073323NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK114456
6 · The paper itself

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of infants that is characterized by interrupted lung development. Postnatal sepsis causes BPD, yet the contributory mechanisms are unclear. To address this gap, studies have used lipopolysaccharide (LPS) during the alveolar phase of lung development. However, the lungs of infants who develop BPD are still in the saccular phase of development, and the effects of LPS during this phase are poorly characterized. We hypothesized that chronic LPS exposure during the saccular phase disrupts lung development by mechanisms that promote inflammation and prevent optimal lung development and repair. Wild-type C57BL6J mice were intraperitoneally administered 3, 6, or 10 mg/kg of LPS or a vehicle once daily on postnatal days (PNDs) 3-5. The lungs were collected for proteomic and genomic analyses and flow cytometric detection on PND6. The impact of LPS on lung development, cell proliferation, and apoptosis was determined on PND7. Finally, we determined differences in the LPS effects between the saccular and alveolar lungs. LPS decreased the survival and growth rate and lung development in a dose-dependent manner. These effects were associated with a decreased expression of proteins regulating cell proliferation and differentiation and increased expression of those mediating inflammation. While the lung macrophage population of LPS-treated mice increased, the T-regulatory cell population decreased. Furthermore, LPS-induced inflammatory and apoptotic response and interruption of cell proliferation and alveolarization was greater in alveolar than in saccular lungs. Collectively, the data support our hypothesis and reveal several potential therapeutic targets for sepsis-mediated BPD in infants.

Indexed as

AnimalsAnimals, NewbornCell ProliferationDose-Response Relationship, DrugInflammationLipopolysaccharidesMicePulmonary AlveoliT-Lymphocytes, RegulatoryLipopolysaccharidesbronchopulmonary dysplasiainflammationlipopolysaccharideproteomicsT-regulatory cells

Identifiers

PMID30307313
PMCPMC6383495
OpenAlexW2895958523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.